-
Journal of Hepatology Jan 2006
Review
Topics: Humans; Liver Cirrhosis; Prognosis; Survival Rate
PubMed: 16298014
DOI: 10.1016/j.jhep.2005.10.013 -
The Journal of ECT Jun 2021Involuntary electroconvulsive therapy (ECT) can be a lifesaving intervention for patients suffering from potentially lethal conditions who are unable to give informed...
OBJECTIVE
Involuntary electroconvulsive therapy (ECT) can be a lifesaving intervention for patients suffering from potentially lethal conditions who are unable to give informed consent. However, its use is not widespread, probably partly because of the scarce data on hard outcomes following involuntary ECT. In Denmark, involuntary ECT is only used when patients are at imminent/potential risk of dying if not receiving ECT. Here, we aimed to estimate the 1-year survival rate after the administration of involuntary ECT as a proxy for the effectiveness of this treatment.
METHODS
We conducted a register-based cohort study involving (i) all patients receiving involuntary ECT in Denmark between 2008 and 2019, (ii) age- and sex-matched patients receiving voluntary ECT, and (iii) age- and sex-matched individuals from the general population. One-year survival rates were compared via mortality rate ratios.
RESULTS
We identified 618 patients receiving involuntary ECT, 547 patients receiving voluntary ECT, and 3080 population-based controls. The survival rate in the year after involuntary ECT was 90%. For patients receiving involuntary ECT, the 1-year mortality rate ratios were 3.1 (95% confidence interval, 1.9-5.2) and 5.8 (95% confidence interval, 4.0-8.2) compared with those receiving voluntarily ECT and to the population-based controls, respectively. Risk factors for early death among patients receiving involuntary ECT were male sex, being 70 years or older and having organic mental disorder as the treatment indication.
CONCLUSIONS
Treatment with involuntary ECT is associated with a high survival rate, suggesting that the intervention is effective. However, patients receiving involuntary ECT constitute a high-risk population that should be monitored closely after this treatment.
Topics: Cohort Studies; Electroconvulsive Therapy; Humans; Male; Survival Rate
PubMed: 33337646
DOI: 10.1097/YCT.0000000000000736 -
American Journal of Orthodontics and... Jan 2019
Topics: Dental Bonding; Orthodontic Appliances, Fixed; Orthodontic Retainers; Orthodontic Wires; Survival Rate; Treatment Outcome
PubMed: 30591163
DOI: 10.1016/j.ajodo.2018.09.009 -
Journal of Psychosomatic Research Oct 2016Although the predictive value of vagal nerve activity, indexed by heart rate variability (HRV), has been confirmed in a variety of diseases, its value in the prediction... (Meta-Analysis)
Meta-Analysis Review
PURPOSE
Although the predictive value of vagal nerve activity, indexed by heart rate variability (HRV), has been confirmed in a variety of diseases, its value in the prediction of survival in cancer patients still remains controversial. The aim of this meta-analysis was to evaluate the predictive value of HRV in cancer patients in an evidence based manner.
METHODS
A systematic review and meta-analysis was conducted through a comprehensive search of the PubMed, EMBASE and the Cochrane Central Library databases for all studies regarding HRV, vagal nerve activity and cancer. Pooled data of overall survival was analyzed.
RESULTS
Six studies with 1286 patients were included in our meta analysis. Analysis of the pooled data revealed that overall survival was significantly longer in the higher HRV group than in the lower HRV group (HR 0.70, 95% CI [0.60, 0.82]; P<0.001, I2=27%).
CONCLUSION
The current evidence indicates a predictive value of HRV in the survival of patients with cancer and higher vagal nerve activity might predict longer survival, but the results should be applied with caution considering the heterogeneity between included studies.
Topics: Heart Rate; Humans; Neoplasms; Predictive Value of Tests; Survival Rate; Vagus Nerve
PubMed: 27663106
DOI: 10.1016/j.jpsychores.2016.08.004 -
Acta Radiologica Jan 1953
Topics: Biometry; Humans; Neoplasms; Statistics as Topic; Survival Rate
PubMed: 13030320
DOI: 10.3109/00016925309136688 -
World Neurosurgery Dec 2021A chordoma is a slow-growing, invasive neoplasm in the neuraxis that is thought to arise from notochordal cells. At 10-year follow-up, the average survival rate is 50%,... (Review)
Review
BACKGROUND
A chordoma is a slow-growing, invasive neoplasm in the neuraxis that is thought to arise from notochordal cells. At 10-year follow-up, the average survival rate is 50%, though individual prognosis varies substantially. We aimed to provide a comprehensive overview of the genes and proteins expressed in these tumors and their prognostic value to facilitate prognostication for patients with chordoma.
METHODS
A systematic search of clinical studies that investigated expressed factors related to chordoma survival was performed in PubMed. Data extracted included RNA and protein expression data and prognostic value (in terms of overall survival, progression-free survival, disease-free survival, and recurrence-free survival) from univariate and multivariate analyses.
RESULTS
This review included 78 original studies that collectively evaluated 134 expressed factors. Of these molecular factors, 96 by univariate analysis and 32 by multivariate analysis had a predictive value for patient survival. Of the molecular factors studied in multivariate analyses, 26 factors had a negative effect while 6 had a positive effect on patient survival.
CONCLUSIONS
Identification of molecular factors that are associated with survival contributes to better prognostication of patients with chordoma. Given the rarity of chordoma, often only univariate analyses can be performed. Robust multivariate analyses are scarcer but provide independently significant prognostic factors. The data presented in this review can aid in prognostication for the individual patient and facilitate the development of targeted therapies.
Topics: Biomarkers, Tumor; Chordoma; Gene Regulatory Networks; Humans; Prognosis; Survival Rate
PubMed: 34530149
DOI: 10.1016/j.wneu.2021.09.027 -
European Journal of Heart Failure Sep 2015Heart failure (HF) is an epidemic in healthcare worldwide, including Asia. It appears that HF will become more serious in the near future, with the epidemiological... (Review)
Review
Heart failure (HF) is an epidemic in healthcare worldwide, including Asia. It appears that HF will become more serious in the near future, with the epidemiological transition and ageing of the population. However, in contrast to Western countries, information on HF epidemiology is still limited in Asia, particularly in South Asia. In this review, we will briefly summarize available information regarding the current and future burden of HF in Asia, which indicates the importance of both primary prevention of underlying diseases of HF and secondary prevention, including management of ischaemic HF, HF with preserved EF, and HF in the elderly.
Topics: Asia; Heart Failure; Humans; Morbidity; Registries; Survival Rate
PubMed: 26222508
DOI: 10.1002/ejhf.319 -
The Journal of Oral Implantology Aug 2022
Topics: Dental Implants; Dental Prosthesis, Implant-Supported; Dental Restoration Failure; Survival Rate; Tooth
PubMed: 36054134
DOI: 10.1563/aaid-joi-D-22-Editorial.4804 -
The Journal of Craniofacial Surgery Jun 2022
Topics: Emergency Medical Services; Humans; Quality of Life; Survival Rate; Technology
PubMed: 36041101
DOI: 10.1097/SCS.0000000000008793 -
Technology and Health Care : Official... 2023The survival rate of experimental animals is a very important index in chemical toxicity evaluation experiments. The calculation of nematode survival rate is used in...
BACKGROUND
The survival rate of experimental animals is a very important index in chemical toxicity evaluation experiments. The calculation of nematode survival rate is used in many experiments.
OBJECTIVE
Traditional survival rate quantification methods require manual counting. This is a time-consuming and laborious work when using 384-well plate for high-throughput chemical toxicity assessment experiments. At present, there is a great need for an automatic method to identify the survival rate of nematodes in the experiment of chemical toxicity evaluation.
METHODS
We designed an automatic nematode survival rate recognition method by combining the bright field experimental image of nematodes and the dark field image of nematodes which is captured after adding Propidium Iodide dye, and used it to calculate the nematode survival rate in different chemical environments. Experiment results show that the survival rate obtained by our automatic counting method is very similar to the survival rate obtained by manual counting.
RESULTS
Through several different chemical experiments, we can see that chemicals with different toxicity have different effects on the survival rate of nematodes. And the survival rate of nematodes under different chemical concentrations has an obvious gradient trend from high concentration to low concentration. In addition, our method can quantify the motility of nematodes. There are also significant differences in the motility of nematodes cultured in different chemical environments. Moreover, the nematode motility under different chemical concentrations showed an obvious gradient change trend from high concentration to low concentration.
CONCLUSION
Our study provides an accurate and efficient nematode survival rate recognition method for chemical toxicology research.
Topics: Animals; Survival Rate; Bone Plates; Nematoda
PubMed: 37038792
DOI: 10.3233/THC-236017